Thus, herein, we review evidence from both preclinical and clinical studies of BDNF in pediatric ABI, focusing on three key insults, namely, TBI, global cerebral ischemia, and stroke, suggesting that peripheral BDNF concentrations, genotype, and DNAm may be markers of survival and recovery. This evidence concerns the gene BDNF and Stroke.